These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14632700)

  • 1. The impact of screening for Type 2 diabetes in siblings of patients with established diabetes.
    Farmer AJ; Doll H; Levy JC; Salkovskis PM
    Diabet Med; 2003 Dec; 20(12):996-1004. PubMed ID: 14632700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In a randomized trial, outcomes were not affected by intensive follow-up over 1 year.
    Farmer AJ; Doll HA
    J Clin Epidemiol; 2005 Oct; 58(10):991-6. PubMed ID: 16168344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice.
    Park P; Simmons RK; Prevost AT; Griffin SJ
    BMC Public Health; 2008 Oct; 8():350. PubMed ID: 18840266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ).
    Nicolucci A; Giorgino R; Cucinotta D; Zoppini G; Muggeo M; Squatrito S; Corsi A; Lostia S; Pappalardo L; Benaduce E; Girelli A; Galeone F; Maldonato A; Perriello G; Pata P; Marra G; Coronel GA
    Diabetes Nutr Metab; 2004 Aug; 17(4):235-43. PubMed ID: 15575345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes screening anxiety and beliefs.
    Skinner TC; Davies MJ; Farooqi AM; Jarvis J; Tringham JR; Khunti K
    Diabet Med; 2005 Nov; 22(11):1497-502. PubMed ID: 16241913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of the Turkish version of the Well-being Questionnaire (WBQ-22) in patients with Type 2 diabetes: the effects of diabetic complications.
    Savli H; Sevinc A
    J Endocrinol Invest; 2005 Sep; 28(8):683-91. PubMed ID: 16277163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of risk of developing diabetes mellitus among siblings of Type 2 diabetic patients.
    Farmer AJ; Levy JC; Turner RC
    Diabet Med; 1999 Mar; 16(3):233-7. PubMed ID: 10227569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study.
    Adriaanse MC; Snoek FJ; Dekker JM; Spijkerman AM; Nijpels G; Twisk JW; van der Ploeg HM; Heine RJ
    Diabet Med; 2004 Sep; 21(9):992-8. PubMed ID: 15317604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The associations of anxiety, depression and personal illness representations with glycaemic control and health-related quality of life in patients with type 2 diabetes mellitus.
    Paschalides C; Wearden AJ; Dunkerley R; Bundy C; Davies R; Dickens CM
    J Psychosom Res; 2004 Dec; 57(6):557-64. PubMed ID: 15596162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for and subsequent participation in a trial for depression and anxiety in people with type 2 diabetes treated in primary care: Who do we reach?
    Stoop CH; Nefs G; Pop VJ; Pouwer F
    Prim Care Diabetes; 2017 Jun; 11(3):273-280. PubMed ID: 28330680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial.
    Eborall HC; Griffin SJ; Prevost AT; Kinmonth AL; French DP; Sutton S
    BMJ; 2007 Sep; 335(7618):486. PubMed ID: 17761995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diabetes on learning in children.
    McCarthy AM; Lindgren S; Mengeling MA; Tsalikian E; Engvall JC
    Pediatrics; 2002 Jan; 109(1):E9. PubMed ID: 11773577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial.
    Paddison CA; Eborall HC; Sutton S; French DP; Vasconcelos J; Prevost AT; Kinmonth AL; Griffin SJ
    BMJ; 2009 Nov; 339():b4535. PubMed ID: 19948642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial.
    Paddison CA; Eborall HC; French DP; Kinmonth AL; Prevost AT; Griffin SJ; Sutton S
    Br J Health Psychol; 2011 Feb; 16(Pt 1):213-26. PubMed ID: 21226792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening Study.
    Adriaanse MC; Dekker JM; Spijkerman AM; Twisk JW; Nijpels G; van der Ploeg HM; Heine RJ; Snoek FJ
    Qual Life Res; 2005 Aug; 14(6):1501-9. PubMed ID: 16110930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are the combined effects of negative emotions and illness cognitions on self-care in people with type 2 diabetes? A longitudinal structural equation model.
    Hudson JL; Bundy C; Coventry P; Dickens C; Wood A; Reeves D
    Psychol Health; 2016 Jul; 31(7):873-90. PubMed ID: 26988897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irish diabetes detection programme in general practice.
    Smith SM; Holohan J; McAuliffe A; Firth RG
    Diabet Med; 2003 Sep; 20(9):717-22. PubMed ID: 12925050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental predictive value of screening for anxiety and depression beyond current type 2 diabetes risk models: a prospective cohort study.
    Atlantis E; Ghassem Pour S; Girosi F
    BMJ Open; 2018 Jan; 8(1):e018255. PubMed ID: 29362254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and Self-Efficacy in Patients with Type 2 Diabetes in Northern Greece.
    Sympa P; Vlachou E; Kazakos K; Govina O; Stamatiou G; Lavdaniti M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):371-378. PubMed ID: 29165096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cluster-randomised controlled trial.
    Simmons RK; Bruun NH; Witte DR; Borch-Johnsen K; Jørgensen ME; Sandbæk A; Lauritzen T
    Diabetologia; 2017 Jun; 60(6):1016-1021. PubMed ID: 28280901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.